Antibiotice S.A. Logo

Antibiotice S.A.

ATB | RO

Overview

Corporate Details

ISIN(s):
ROATBIACNOR9
LEI:
315700P5G4O1L6GLMS02
Country:
Romania
Address:
VALEA LUPULUI, 707410 IAȘI
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Antibiotice S.A. is a Romanian pharmaceutical company specializing in the research, development, and manufacturing of generic drugs. The company operates eight GMP-certified manufacturing lines, producing a portfolio that includes sterile injectable products and active pharmaceutical ingredients (APIs). It holds U.S. Food and Drug Administration (FDA) approval for key products such as Ampicillin, Nafcillin, and the API Nystatin, demonstrating its commitment to international quality standards. Guided by a mission to make valuable medicines accessible and affordable, Antibiotice serves patients, physicians, and pharmacists in domestic and international markets.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Antibiotice S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-04 12:29
Notice of Dividend Amount
Plata dividend - RC17
Romanian 2.1 MB
2025-08-13 12:27
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB
2025-08-06 12:40
Report Publication Announcement
Raport curent de informare a investitorilor
Romanian 137.7 KB
2025-07-24 12:07
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.6 MB
2025-07-09 12:28
Board/Management Information
Raport curent de informare a investitorilor
Romanian 491.4 KB
2025-07-01 11:49
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 606.7 KB
2025-06-20 14:01
Board/Management Information
Raport curent de informare a investitorilor
Romanian 168.7 KB
2025-06-05 11:06
Regulatory News Service
Raport curent de informare a investitorilor
Romanian 752.7 KB
2025-05-27 15:21
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB
2025-05-26 12:34
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 1.4 MB
2025-05-15 12:05
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 749.5 KB
2025-04-23 11:35
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.6 MB
2025-04-22 15:11
Pre-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 3.9 MB
2025-03-13 07:54
Notice of Dividend Amount
Raport curent de informare a investitorilor
Romanian 688.4 KB
2025-03-13 07:50
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB

Automate Your Workflow. Get a real-time feed of all Antibiotice S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Antibiotice S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Otsuka Holdings Co., Ltd. Logo Japan 4578
Oxford Biomedica PLC Logo
A CDMO for cell & gene therapy, providing end-to-end viral vector development & manufacturing.
United Kingdom OXB
PAION AG Logo
Developed innovative drugs for hospital sedation, anesthesia, and critical care.
Germany PA8
PeptiDream Inc. Logo Japan 4587
PEPTONIC Medical AB Logo
Develops clinically proven self-care products and diagnostics for women's intimate health.
Sweden PMED
Perseus Proteomics Inc. Logo Japan 4882
Pharma Mar S.A. Logo
Develops and commercializes marine-derived oncology treatments for rare cancers.
Spain PHM
Pharmanutra Logo
Develops science-backed nutraceuticals & pharmaceuticals for nutritional & joint health.
Italy PHN
PharmaSGP Holding SE Logo
Develops & distributes natural, pharmacy-exclusive OTC drugs for chronic conditions in Europe.
Germany PSG
Pharmena S.A. Logo
Develops patented 1-MNA molecule for dermocosmetics and supplements in EU & North American markets.
Poland PHR